WO2002096347A3 - Metering and packaging of controlled release medication - Google Patents

Metering and packaging of controlled release medication Download PDF

Info

Publication number
WO2002096347A3
WO2002096347A3 PCT/US2002/016185 US0216185W WO02096347A3 WO 2002096347 A3 WO2002096347 A3 WO 2002096347A3 US 0216185 W US0216185 W US 0216185W WO 02096347 A3 WO02096347 A3 WO 02096347A3
Authority
WO
WIPO (PCT)
Prior art keywords
metering
controlled release
packaging
release medication
medication
Prior art date
Application number
PCT/US2002/016185
Other languages
French (fr)
Other versions
WO2002096347A2 (en
Inventor
Andrew L Abrams
Anand V Gumaste
Original Assignee
Microdose Technologies Inc
Andrew L Abrams
Anand V Gumaste
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microdose Technologies Inc, Andrew L Abrams, Anand V Gumaste filed Critical Microdose Technologies Inc
Priority to US10/479,438 priority Critical patent/US20040156903A1/en
Priority to EP02731902A priority patent/EP1408907A4/en
Priority to JP2002592860A priority patent/JP2005514966A/en
Priority to CA002448997A priority patent/CA2448997A1/en
Priority to AU2002303840A priority patent/AU2002303840A1/en
Priority to NZ529696A priority patent/NZ529696A/en
Priority to BRPI0209720A priority patent/BRPI0209720A2/en
Publication of WO2002096347A2 publication Critical patent/WO2002096347A2/en
Publication of WO2002096347A3 publication Critical patent/WO2002096347A3/en
Priority to US11/549,492 priority patent/US20070087048A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release

Abstract

Controlled quantities of powdered medication are formed in controlled release packages using electrostating metering. Also provided are combination medication therapy delivery packages comprising two or more active pharmaceuticals segregated from one another in a single delivery package.
PCT/US2002/016185 2001-05-31 2002-05-22 Metering and packaging of controlled release medication WO2002096347A2 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
US10/479,438 US20040156903A1 (en) 2002-05-22 2002-05-22 Metering and packaging of controlled release medication
EP02731902A EP1408907A4 (en) 2001-05-31 2002-05-22 Metering and packaging of controlled release medication
JP2002592860A JP2005514966A (en) 2001-05-31 2002-05-22 Controlled release drug metering and packaging
CA002448997A CA2448997A1 (en) 2001-05-31 2002-05-22 Metering and packaging of controlled release medication
AU2002303840A AU2002303840A1 (en) 2001-05-31 2002-05-22 Metering and packaging of controlled release medication
NZ529696A NZ529696A (en) 2001-05-31 2002-05-22 Metering and packaging of controlled release medication
BRPI0209720A BRPI0209720A2 (en) 2001-05-31 2002-05-22 dosage and packaging of controlled release medication
US11/549,492 US20070087048A1 (en) 2001-05-31 2006-10-13 Oral dosage combination pharmaceutical packaging

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29478601P 2001-05-31 2001-05-31
US60/294,786 2001-05-31

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US11/549,492 Continuation-In-Part US20070087048A1 (en) 2001-05-31 2006-10-13 Oral dosage combination pharmaceutical packaging

Publications (2)

Publication Number Publication Date
WO2002096347A2 WO2002096347A2 (en) 2002-12-05
WO2002096347A3 true WO2002096347A3 (en) 2003-03-27

Family

ID=23134944

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/016185 WO2002096347A2 (en) 2001-05-31 2002-05-22 Metering and packaging of controlled release medication

Country Status (8)

Country Link
EP (1) EP1408907A4 (en)
JP (1) JP2005514966A (en)
AU (1) AU2002303840A1 (en)
BR (1) BRPI0209720A2 (en)
CA (3) CA2614902A1 (en)
NZ (1) NZ529696A (en)
WO (1) WO2002096347A2 (en)
ZA (1) ZA200402466B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8991390B2 (en) 2010-01-05 2015-03-31 Microdose Therapeutx, Inc. Inhalation device and method
US9132246B2 (en) 2007-10-09 2015-09-15 Microdose Therapeutx, Inc. Inhalation device

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6428809B1 (en) 1999-08-18 2002-08-06 Microdose Technologies, Inc. Metering and packaging of controlled release medication
US7670612B2 (en) 2002-04-10 2010-03-02 Innercap Technologies, Inc. Multi-phase, multi-compartment capsular delivery apparatus and methods for using same
AR040672A1 (en) * 2002-07-25 2005-04-13 Glaxo Group Ltd MULTI-COMPONENT PHARMACEUTICAL DOSAGE FORM, PROPER BODY TO BE USED IN THE SAME AND PROCEDURE TO PREPARE IT
US20100260669A1 (en) * 2004-05-13 2010-10-14 Anthony Joonkyoo Yun Treatment of Seasonal Conditions Through Modulation of the Autonomic Nervous System
US8912908B2 (en) 2005-04-28 2014-12-16 Proteus Digital Health, Inc. Communication system with remote activation
US8802183B2 (en) 2005-04-28 2014-08-12 Proteus Digital Health, Inc. Communication system with enhanced partial power source and method of manufacturing same
EP3827747A1 (en) 2005-04-28 2021-06-02 Otsuka Pharmaceutical Co., Ltd. Pharma-informatics system
WO2007047371A2 (en) * 2005-10-14 2007-04-26 Microdose Technologies, Inc. Pharmaceutical packaging of an oral dosage combination
US9270025B2 (en) 2007-03-09 2016-02-23 Proteus Digital Health, Inc. In-body device having deployable antenna
AU2009281876B2 (en) 2008-08-13 2014-05-22 Proteus Digital Health, Inc. Ingestible circuitry
CN102458236B (en) 2009-04-28 2016-01-27 普罗秋斯数字健康公司 The Ingestible event marker of high reliability and using method thereof
BR112012025650A2 (en) 2010-04-07 2020-08-18 Proteus Digital Health, Inc. miniature ingestible device
JP2014504902A (en) * 2010-11-22 2014-02-27 プロテウス デジタル ヘルス， インコーポレイテッド Ingestible device with medicinal product
US9756874B2 (en) 2011-07-11 2017-09-12 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
WO2015112603A1 (en) 2014-01-21 2015-07-30 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
US9271897B2 (en) 2012-07-23 2016-03-01 Proteus Digital Health, Inc. Techniques for manufacturing ingestible event markers comprising an ingestible component
SG11201503027SA (en) 2012-10-18 2015-05-28 Proteus Digital Health Inc Apparatus, system, and method to adaptively optimize power dissipation and broadcast power in a power source for a communication device
JP2016508529A (en) 2013-01-29 2016-03-22 プロテウス デジタル ヘルス， インコーポレイテッド Highly expandable polymer film and composition containing the same
JP5941240B2 (en) 2013-03-15 2016-06-29 プロテウス デジタル ヘルス， インコーポレイテッド Metal detector device, system and method
US9796576B2 (en) 2013-08-30 2017-10-24 Proteus Digital Health, Inc. Container with electronically controlled interlock
US10084880B2 (en) 2013-11-04 2018-09-25 Proteus Digital Health, Inc. Social media networking based on physiologic information
US11051543B2 (en) 2015-07-21 2021-07-06 Otsuka Pharmaceutical Co. Ltd. Alginate on adhesive bilayer laminate film
KR102051875B1 (en) 2016-07-22 2019-12-04 프로테우스 디지털 헬스, 인코포레이티드 Electromagnetic detection and detection of ingestible event markers
EP3531901A4 (en) 2016-10-26 2021-01-27 Proteus Digital Health, Inc. Methods for manufacturing capsules with ingestible event markers

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4795644A (en) * 1987-08-03 1989-01-03 Merck & Co., Inc. Device for pH independent release of drugs through the Donnan-like influence of charged insoluble resins
US5960609A (en) * 1998-06-12 1999-10-05 Microdose Technologies, Inc. Metering and packaging method and device for pharmaceuticals and drugs

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4808413A (en) * 1987-04-28 1989-02-28 E. R. Squibb & Sons, Inc. Pharmaceutical compositions in the form of beadlets and method
US5714007A (en) 1995-06-06 1998-02-03 David Sarnoff Research Center, Inc. Apparatus for electrostatically depositing a medicament powder upon predefined regions of a substrate
US5699649A (en) 1996-07-02 1997-12-23 Abrams; Andrew L. Metering and packaging device for dry powders
FR2771010B1 (en) * 1997-11-19 2003-08-15 Adir USE OF A COMBINATION OF AN ANGIOTENSIN CONVERSION ENZYME INHIBITOR AND A DIURETIC FOR THE TREATMENT OF MICROCIRCULATORY DISORDERS
US6428809B1 (en) * 1999-08-18 2002-08-06 Microdose Technologies, Inc. Metering and packaging of controlled release medication

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4795644A (en) * 1987-08-03 1989-01-03 Merck & Co., Inc. Device for pH independent release of drugs through the Donnan-like influence of charged insoluble resins
US5960609A (en) * 1998-06-12 1999-10-05 Microdose Technologies, Inc. Metering and packaging method and device for pharmaceuticals and drugs

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1408907A4 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9132246B2 (en) 2007-10-09 2015-09-15 Microdose Therapeutx, Inc. Inhalation device
US9539400B2 (en) 2007-10-09 2017-01-10 Microdose Therapeutx, Inc. Inhalation device
US8991390B2 (en) 2010-01-05 2015-03-31 Microdose Therapeutx, Inc. Inhalation device and method

Also Published As

Publication number Publication date
AU2002303840A1 (en) 2002-12-09
NZ529696A (en) 2008-07-31
EP1408907A2 (en) 2004-04-21
CA2614902A1 (en) 2002-12-05
CA2448997A1 (en) 2002-12-05
EP1408907A4 (en) 2010-02-24
CA2614899A1 (en) 2002-12-05
WO2002096347A2 (en) 2002-12-05
ZA200402466B (en) 2006-07-26
JP2005514966A (en) 2005-05-26
BRPI0209720A2 (en) 2017-06-13

Similar Documents

Publication Publication Date Title
WO2002096347A3 (en) Metering and packaging of controlled release medication
AU6909800A (en) Metering and packaging of controlled release medication
WO2003035137A3 (en) Method and apparatus for dispensing inhalator medicament
IL161682A0 (en) A medicament container, a medicament dispensing kit for administering medication and a method for packaging the same
WO2004009445A3 (en) Packaging and dispensing of rapid dissolve dosage form
WO2007047371A3 (en) Pharmaceutical packaging of an oral dosage combination
HK1046244A1 (en) Controlled release and taste masking oral pharmaceutical compositions.
HUP0401029A3 (en) Pack containing medicament and dispensing device
CA2398893A1 (en) Improvements in and relating to controlling drug delivery apparatus
PL324333A1 (en) Inhaler for administering drugs from blister packages
AU8458991A (en) Pharmaceutical composition in gel form in a dispensing package
WO2000075039A3 (en) Child-resistant packaging for tablets
WO2002091987A3 (en) A medicine dispenser
WO2003043678A3 (en) Syringe bandolier with control feature
WO2004112756A8 (en) Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
AU2001233258A1 (en) Interactive blister package
MXPA00001924A (en) Gelatin-free, flexible and useful encapsulating material for drugs, paint balls and other formulations.
HK1083200A1 (en) Pharmaceutical preparations for oral administration, containing ion- exchange resins loaded with active ingredients and intrinsically viscous gelling agents as thickening agents
BR9908815A (en) Inhalation device
WO2005063203A3 (en) Multiparticulate formulations for oral delivery
ATE327794T1 (en) MEDICATION PACKAGING AND DISPENSING DEVICE THEREOF
WO2001082874A3 (en) A medicinal aerosol formulation
AU4916501A (en) Packaging materials for transdermal drug delivery systems
WO2005009322A3 (en) Delivery system for topical medications
CA2185883A1 (en) The use of dimeticone as a transport and carrier system and/or drug delivery system

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 529696

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 2002731902

Country of ref document: EP

Ref document number: 1856/CHENP/2003

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 2448997

Country of ref document: CA

Ref document number: 2002592860

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 10479438

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2004/02466

Country of ref document: ZA

Ref document number: 200402466

Country of ref document: ZA

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 2002731902

Country of ref document: EP

ENPW Started to enter national phase and was withdrawn or failed for other reasons

Ref document number: PI0209720

Country of ref document: BR

Free format text: PEDIDO RETIRADO FACE A IMPOSSIBILIDADE DE ACEITACAO DA ENTRADA NA FASE NACIONAL POR TER SIDO INTEMPESTIVA. O PRAZO PARA ENTRADA NA FASE NACIONAL EXPIRAVA EM 31.01.2003( 20 MESES - BR DESIGNADO APENAS), ELEICAO NAO COMPROVADA, E A PRETENSA ENTRADA NA FASE NACIONAL SO OCORREU EM 27.11.2003.

ENP Entry into the national phase

Ref document number: PI0209720

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20031127